SLC2A4 and polycystic ovary syndrome: Consistent with these results, in chronic insulin resistance or hyperinsulinemia conditions such as obesity and polycystic ovary syndrome (PCOS), endocytosis of GLUT4 is induced, GLUT4 translocation to the plasma membrane is inhibited, and GLUT4 expression is reduced in target tissues [55].